SlideShare a Scribd company logo
Fat Transfer to the Upper and Lower Extremities
in Patients With Raynaud’s Phenomenon –
A Novel Therapeutic Modality
Lawrence S. Zachary, MD
Section of Plastic and Reconstructive Surgery
Department of SurgeryNo disclosures
2
Raynaud’s Phenomenon
Fat Transfer in Raynaud’s
3
Raynaud’s Phenomenon
PrimaryVasoconstriction
Cold attacks
Pain
Secondary
Fibrosis
Scarring
Contracture
Ulceration
Autoamputation
Fat Transfer in Raynaud’s
4Fat Transfer in Raynaud’s
Treatment
Ca Channel
Blockers
ARB
Protective
Measures
Protective
Measures PDE-I
Clopidogrel
Endothelin
Receptor
Blockers
Alpha
Blockers
Topical
Nitrates
ACE-I
ASA
Prostanoids
5Fat Transfer in Raynaud’s
Treatment
Ca Channel
Blockers
ARB
Protective
Measures
Protective
Measures
PDE-I
Clopidogrel
Endothelin
Receptor
Blockers
Alpha
Blockers
Topical
Nitrates
ACE-I
ASA
Prostanoids
Invasive
Modalities
Surgical
Sympathectomy
Neuro-
modulators
Fat TransferFat Transfer
• Clinical improvement – radiation dermatitis, burns
• Histological evidence – Sultan, PRS 2011
– Radiation dermatitis murine model  fat injection
– Regression of hyperpigmentation, ulcers and fibrosis
– Improvements in the inflammatory, microvascular,
and fibrotic characteristics
• Mechanism unclear –
Restoration of depleted adipose-derived stem cells?
6Fat Transfer in Raynaud’s
Fat Transfer Rationale
Raynaud’s - different pathogenesis – similar end effect
7Fat Transfer in Raynaud’s
Goal
as a means to delay progression of
Raynaud’s Phenomenon
after failure of medical management
as a means to delay progression of
Raynaud’s Phenomenon
after failure of medical management
Utilize fat graftingUtilize fat grafting
• Adaptation of rejuvenation of the hand by fat grafting
• Approximately 30 ml of decanted fat
• Abdominal depots
• Injected via blunt cannulae into the affected extremity
8Fat Transfer in Raynaud’s
Technique
9Fat Transfer in Raynaud’s
Technique
10 ml - dorsum of hand
3 ml - snuff-box
2-3 ml - each dorsal webspace
6 ml - along palmar arch
1 ml - palmar webspaces 2-4
2 ml - first webspace
2 ml - ulnar border of small finger
10Fat Transfer in Raynaud’s
Technique
11
Results
Fat Transfer in Raynaud’s
Total patients 14
Total extremities 25
Hand 20
Feet 5
Mean follow up 12 months (4-17)
Female: Male 13:1
Primary: Secondary 8:6
Average fat injected 23.29 ml (10-30)
Concomitant digital sympathectomy 4
12
Results
Overall improvement 92.5% of patients
Pain reduction 85.7% (7  2.6)
1 patient – no change
1 patient – increased pain
Cold attacks 78.5% decreased frequency
and severity
Ulcerations 66% improvement
Major complications 0
Minor complications 2
Subsequent neuromodulator 1
Subsequent sympathectomy 1
Fat Transfer in Raynaud’s
13Fat Transfer in Raynaud’s
14Fat Transfer in Raynaud’s
15Fat Transfer in Raynaud’s
16Fat Transfer in Raynaud’s
17Fat Transfer in Raynaud’s
18Fat Transfer in Raynaud’s
Hand Vascular Perfusion by Laser Doppler
Normal Moderate Severe
19Fat Transfer in Raynaud’s
Hand Vascular Perfusion by Laser Doppler
20Fat Transfer in Raynaud’s
Hand Vascular Perfusion by Laser Doppler
21Fat Transfer in Raynaud’s
Preop Postop
200
150
100
50
Perfusionunits
Hand Vascular Perfusion by Laser Doppler
?QMRADASH
Durable clinical improvement in the majority of treated patients
Safe, relatively straightforward
Mechanism – to be elucidated (stem cell angiogenesis? padding?)
Role in treatment of advanced, refractory Raynaud’s Phenomenon
22
Conclusions
Fat Transfer in Raynaud’s
Thank You

More Related Content

Similar to Fat Transfer to the Upper and Lower Extremities in Patients with Raynaud's Phenomenon

Renal Denervation in Resistant Hypertension 23.pptx
Renal Denervation in Resistant Hypertension 23.pptxRenal Denervation in Resistant Hypertension 23.pptx
Renal Denervation in Resistant Hypertension 23.pptx
Prerna806536
 
Deep Vein Thrombosis.pptx
Deep Vein Thrombosis.pptxDeep Vein Thrombosis.pptx
Deep Vein Thrombosis.pptx
Olofin Kayode
 
Sepsis power point presentation
Sepsis power point presentationSepsis power point presentation
Sepsis power point presentation
dlecolst
 
Novel oral Anticoagulants : Right decision , right choice
Novel oral Anticoagulants : Right decision , right choiceNovel oral Anticoagulants : Right decision , right choice
Novel oral Anticoagulants : Right decision , right choice
SYEDRAZA56411
 
Presentation1.pptx
Presentation1.pptxPresentation1.pptx
Presentation1.pptx
Ritasman Baisya
 
Septic shock
Septic shockSeptic shock
Septic shock
Pritish Chandra Patra
 
Advanced&metastatic breast cancer
Advanced&metastatic breast cancerAdvanced&metastatic breast cancer
Advanced&metastatic breast cancer
Mahran Alnahmi
 
Benamer H
Benamer HBenamer H
Posibilidades del tratamiento percutáneo
Posibilidades del tratamiento percutáneoPosibilidades del tratamiento percutáneo
Posibilidades del tratamiento percutáneo
Sociedad Española de Cardiología
 
Carfilzomib in multiple myeloma
Carfilzomib in multiple myelomaCarfilzomib in multiple myeloma
Carfilzomib in multiple myeloma
Seth g s medical college and kem hospital mumbai
 
peripheralvasculardiseases-210612154006 (1).pptx
peripheralvasculardiseases-210612154006 (1).pptxperipheralvasculardiseases-210612154006 (1).pptx
peripheralvasculardiseases-210612154006 (1).pptx
RAKSHITHMS11
 
Peripheral vascular diseases
Peripheral vascular diseasesPeripheral vascular diseases
Peripheral vascular diseases
Shambhavi Sharma
 
recommandations ESC 2012 sur les pathologies valvulaires cardiaques
recommandations ESC 2012 sur les pathologies valvulaires cardiaquesrecommandations ESC 2012 sur les pathologies valvulaires cardiaques
recommandations ESC 2012 sur les pathologies valvulaires cardiaques
siham h.
 
Early Goal Directed Therapy in 2015
Early Goal Directed Therapy in 2015Early Goal Directed Therapy in 2015
Early Goal Directed Therapy in 2015
Yazan Kherallah
 
Raynauds Phenomenon-Dignosis & Evaluation
Raynauds Phenomenon-Dignosis & Evaluation Raynauds Phenomenon-Dignosis & Evaluation
Raynauds Phenomenon-Dignosis & Evaluation
Suneth Weerarathna
 
PERCUTANEOUS TREATMENT STRATEGIES OF VALVULAR HEART DISEASE
PERCUTANEOUS TREATMENT STRATEGIES OF VALVULAR HEART DISEASEPERCUTANEOUS TREATMENT STRATEGIES OF VALVULAR HEART DISEASE
PERCUTANEOUS TREATMENT STRATEGIES OF VALVULAR HEART DISEASE
Praveen Nagula
 
Remote Ischaemic Conditioning: A Paper Review & Uses in Paramedic Practice
Remote Ischaemic Conditioning: A Paper Review & Uses in Paramedic PracticeRemote Ischaemic Conditioning: A Paper Review & Uses in Paramedic Practice
Remote Ischaemic Conditioning: A Paper Review & Uses in Paramedic Practice
bgander23
 
2017 esc guideline on management of stemi
2017 esc guideline on management of stemi2017 esc guideline on management of stemi
2017 esc guideline on management of stemi
এ হক
 
Portal Hypertension
Portal HypertensionPortal Hypertension
Portal Hypertension
Sumit Roy
 
DIABETES AND THE EYE.pptx
DIABETES AND THE EYE.pptxDIABETES AND THE EYE.pptx
DIABETES AND THE EYE.pptx
shahilagaz
 

Similar to Fat Transfer to the Upper and Lower Extremities in Patients with Raynaud's Phenomenon (20)

Renal Denervation in Resistant Hypertension 23.pptx
Renal Denervation in Resistant Hypertension 23.pptxRenal Denervation in Resistant Hypertension 23.pptx
Renal Denervation in Resistant Hypertension 23.pptx
 
Deep Vein Thrombosis.pptx
Deep Vein Thrombosis.pptxDeep Vein Thrombosis.pptx
Deep Vein Thrombosis.pptx
 
Sepsis power point presentation
Sepsis power point presentationSepsis power point presentation
Sepsis power point presentation
 
Novel oral Anticoagulants : Right decision , right choice
Novel oral Anticoagulants : Right decision , right choiceNovel oral Anticoagulants : Right decision , right choice
Novel oral Anticoagulants : Right decision , right choice
 
Presentation1.pptx
Presentation1.pptxPresentation1.pptx
Presentation1.pptx
 
Septic shock
Septic shockSeptic shock
Septic shock
 
Advanced&metastatic breast cancer
Advanced&metastatic breast cancerAdvanced&metastatic breast cancer
Advanced&metastatic breast cancer
 
Benamer H
Benamer HBenamer H
Benamer H
 
Posibilidades del tratamiento percutáneo
Posibilidades del tratamiento percutáneoPosibilidades del tratamiento percutáneo
Posibilidades del tratamiento percutáneo
 
Carfilzomib in multiple myeloma
Carfilzomib in multiple myelomaCarfilzomib in multiple myeloma
Carfilzomib in multiple myeloma
 
peripheralvasculardiseases-210612154006 (1).pptx
peripheralvasculardiseases-210612154006 (1).pptxperipheralvasculardiseases-210612154006 (1).pptx
peripheralvasculardiseases-210612154006 (1).pptx
 
Peripheral vascular diseases
Peripheral vascular diseasesPeripheral vascular diseases
Peripheral vascular diseases
 
recommandations ESC 2012 sur les pathologies valvulaires cardiaques
recommandations ESC 2012 sur les pathologies valvulaires cardiaquesrecommandations ESC 2012 sur les pathologies valvulaires cardiaques
recommandations ESC 2012 sur les pathologies valvulaires cardiaques
 
Early Goal Directed Therapy in 2015
Early Goal Directed Therapy in 2015Early Goal Directed Therapy in 2015
Early Goal Directed Therapy in 2015
 
Raynauds Phenomenon-Dignosis & Evaluation
Raynauds Phenomenon-Dignosis & Evaluation Raynauds Phenomenon-Dignosis & Evaluation
Raynauds Phenomenon-Dignosis & Evaluation
 
PERCUTANEOUS TREATMENT STRATEGIES OF VALVULAR HEART DISEASE
PERCUTANEOUS TREATMENT STRATEGIES OF VALVULAR HEART DISEASEPERCUTANEOUS TREATMENT STRATEGIES OF VALVULAR HEART DISEASE
PERCUTANEOUS TREATMENT STRATEGIES OF VALVULAR HEART DISEASE
 
Remote Ischaemic Conditioning: A Paper Review & Uses in Paramedic Practice
Remote Ischaemic Conditioning: A Paper Review & Uses in Paramedic PracticeRemote Ischaemic Conditioning: A Paper Review & Uses in Paramedic Practice
Remote Ischaemic Conditioning: A Paper Review & Uses in Paramedic Practice
 
2017 esc guideline on management of stemi
2017 esc guideline on management of stemi2017 esc guideline on management of stemi
2017 esc guideline on management of stemi
 
Portal Hypertension
Portal HypertensionPortal Hypertension
Portal Hypertension
 
DIABETES AND THE EYE.pptx
DIABETES AND THE EYE.pptxDIABETES AND THE EYE.pptx
DIABETES AND THE EYE.pptx
 

Recently uploaded

June 2024 Oncology Cartoons By Dr Kanhu Charan Patro
June 2024 Oncology Cartoons By Dr Kanhu Charan PatroJune 2024 Oncology Cartoons By Dr Kanhu Charan Patro
June 2024 Oncology Cartoons By Dr Kanhu Charan Patro
Kanhu Charan
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
Health Advances
 
10 Benefits an EPCR Software should Bring to EMS Organizations
10 Benefits an EPCR Software should Bring to EMS Organizations   10 Benefits an EPCR Software should Bring to EMS Organizations
10 Benefits an EPCR Software should Bring to EMS Organizations
Traumasoft LLC
 
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPromoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
PsychoTech Services
 
Test bank for karp s cell and molecular biology 9th edition by gerald karp.pdf
Test bank for karp s cell and molecular biology 9th edition by gerald karp.pdfTest bank for karp s cell and molecular biology 9th edition by gerald karp.pdf
Test bank for karp s cell and molecular biology 9th edition by gerald karp.pdf
rightmanforbloodline
 
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdfMedical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
Jim Jacob Roy
 
Acute Gout Care & Urate Lowering Therapy .pdf
Acute Gout Care & Urate Lowering Therapy .pdfAcute Gout Care & Urate Lowering Therapy .pdf
Acute Gout Care & Urate Lowering Therapy .pdf
Jim Jacob Roy
 
Physical demands in sports - WCSPT Oslo 2024
Physical demands in sports - WCSPT Oslo 2024Physical demands in sports - WCSPT Oslo 2024
Physical demands in sports - WCSPT Oslo 2024
Torstein Dalen-Lorentsen
 
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
FFragrant
 
CBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdfCBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdf
suvadeepdas911
 
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
Kosmoderma Academy Of Aesthetic Medicine
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
rishi2789
 
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấuK CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
HongBiThi1
 
Breast cancer: Post menopausal endocrine therapy
Breast cancer: Post menopausal endocrine therapyBreast cancer: Post menopausal endocrine therapy
Breast cancer: Post menopausal endocrine therapy
Dr. Sumit KUMAR
 
Top Travel Vaccinations in Manchester
Top Travel Vaccinations in ManchesterTop Travel Vaccinations in Manchester
Top Travel Vaccinations in Manchester
NX Healthcare
 
Nano-gold for Cancer Therapy chemistry investigatory project
Nano-gold for Cancer Therapy chemistry investigatory projectNano-gold for Cancer Therapy chemistry investigatory project
Nano-gold for Cancer Therapy chemistry investigatory project
SIVAVINAYAKPK
 
The Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of RespirationThe Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of Respiration
MedicoseAcademics
 
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)
Josep Vidal-Alaball
 
vonoprazan A novel drug for GERD presentation
vonoprazan A novel drug for GERD presentationvonoprazan A novel drug for GERD presentation
vonoprazan A novel drug for GERD presentation
Dr.pavithra Anandan
 
SENSORY NEEDS B.SC. NURSING SEMESTER II.
SENSORY NEEDS B.SC. NURSING SEMESTER II.SENSORY NEEDS B.SC. NURSING SEMESTER II.
SENSORY NEEDS B.SC. NURSING SEMESTER II.
KULDEEP VYAS
 

Recently uploaded (20)

June 2024 Oncology Cartoons By Dr Kanhu Charan Patro
June 2024 Oncology Cartoons By Dr Kanhu Charan PatroJune 2024 Oncology Cartoons By Dr Kanhu Charan Patro
June 2024 Oncology Cartoons By Dr Kanhu Charan Patro
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
 
10 Benefits an EPCR Software should Bring to EMS Organizations
10 Benefits an EPCR Software should Bring to EMS Organizations   10 Benefits an EPCR Software should Bring to EMS Organizations
10 Benefits an EPCR Software should Bring to EMS Organizations
 
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPromoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
 
Test bank for karp s cell and molecular biology 9th edition by gerald karp.pdf
Test bank for karp s cell and molecular biology 9th edition by gerald karp.pdfTest bank for karp s cell and molecular biology 9th edition by gerald karp.pdf
Test bank for karp s cell and molecular biology 9th edition by gerald karp.pdf
 
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdfMedical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
 
Acute Gout Care & Urate Lowering Therapy .pdf
Acute Gout Care & Urate Lowering Therapy .pdfAcute Gout Care & Urate Lowering Therapy .pdf
Acute Gout Care & Urate Lowering Therapy .pdf
 
Physical demands in sports - WCSPT Oslo 2024
Physical demands in sports - WCSPT Oslo 2024Physical demands in sports - WCSPT Oslo 2024
Physical demands in sports - WCSPT Oslo 2024
 
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
 
CBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdfCBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdf
 
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
 
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấuK CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
 
Breast cancer: Post menopausal endocrine therapy
Breast cancer: Post menopausal endocrine therapyBreast cancer: Post menopausal endocrine therapy
Breast cancer: Post menopausal endocrine therapy
 
Top Travel Vaccinations in Manchester
Top Travel Vaccinations in ManchesterTop Travel Vaccinations in Manchester
Top Travel Vaccinations in Manchester
 
Nano-gold for Cancer Therapy chemistry investigatory project
Nano-gold for Cancer Therapy chemistry investigatory projectNano-gold for Cancer Therapy chemistry investigatory project
Nano-gold for Cancer Therapy chemistry investigatory project
 
The Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of RespirationThe Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of Respiration
 
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)
 
vonoprazan A novel drug for GERD presentation
vonoprazan A novel drug for GERD presentationvonoprazan A novel drug for GERD presentation
vonoprazan A novel drug for GERD presentation
 
SENSORY NEEDS B.SC. NURSING SEMESTER II.
SENSORY NEEDS B.SC. NURSING SEMESTER II.SENSORY NEEDS B.SC. NURSING SEMESTER II.
SENSORY NEEDS B.SC. NURSING SEMESTER II.
 

Fat Transfer to the Upper and Lower Extremities in Patients with Raynaud's Phenomenon

  • 1. Fat Transfer to the Upper and Lower Extremities in Patients With Raynaud’s Phenomenon – A Novel Therapeutic Modality Lawrence S. Zachary, MD Section of Plastic and Reconstructive Surgery Department of SurgeryNo disclosures
  • 4. 4Fat Transfer in Raynaud’s Treatment Ca Channel Blockers ARB Protective Measures Protective Measures PDE-I Clopidogrel Endothelin Receptor Blockers Alpha Blockers Topical Nitrates ACE-I ASA Prostanoids
  • 5. 5Fat Transfer in Raynaud’s Treatment Ca Channel Blockers ARB Protective Measures Protective Measures PDE-I Clopidogrel Endothelin Receptor Blockers Alpha Blockers Topical Nitrates ACE-I ASA Prostanoids Invasive Modalities Surgical Sympathectomy Neuro- modulators Fat TransferFat Transfer
  • 6. • Clinical improvement – radiation dermatitis, burns • Histological evidence – Sultan, PRS 2011 – Radiation dermatitis murine model  fat injection – Regression of hyperpigmentation, ulcers and fibrosis – Improvements in the inflammatory, microvascular, and fibrotic characteristics • Mechanism unclear – Restoration of depleted adipose-derived stem cells? 6Fat Transfer in Raynaud’s Fat Transfer Rationale Raynaud’s - different pathogenesis – similar end effect
  • 7. 7Fat Transfer in Raynaud’s Goal as a means to delay progression of Raynaud’s Phenomenon after failure of medical management as a means to delay progression of Raynaud’s Phenomenon after failure of medical management Utilize fat graftingUtilize fat grafting
  • 8. • Adaptation of rejuvenation of the hand by fat grafting • Approximately 30 ml of decanted fat • Abdominal depots • Injected via blunt cannulae into the affected extremity 8Fat Transfer in Raynaud’s Technique
  • 9. 9Fat Transfer in Raynaud’s Technique 10 ml - dorsum of hand 3 ml - snuff-box 2-3 ml - each dorsal webspace 6 ml - along palmar arch 1 ml - palmar webspaces 2-4 2 ml - first webspace 2 ml - ulnar border of small finger
  • 10. 10Fat Transfer in Raynaud’s Technique
  • 11. 11 Results Fat Transfer in Raynaud’s Total patients 14 Total extremities 25 Hand 20 Feet 5 Mean follow up 12 months (4-17) Female: Male 13:1 Primary: Secondary 8:6 Average fat injected 23.29 ml (10-30) Concomitant digital sympathectomy 4
  • 12. 12 Results Overall improvement 92.5% of patients Pain reduction 85.7% (7  2.6) 1 patient – no change 1 patient – increased pain Cold attacks 78.5% decreased frequency and severity Ulcerations 66% improvement Major complications 0 Minor complications 2 Subsequent neuromodulator 1 Subsequent sympathectomy 1 Fat Transfer in Raynaud’s
  • 13. 13Fat Transfer in Raynaud’s
  • 14. 14Fat Transfer in Raynaud’s
  • 15. 15Fat Transfer in Raynaud’s
  • 16. 16Fat Transfer in Raynaud’s
  • 17. 17Fat Transfer in Raynaud’s
  • 18. 18Fat Transfer in Raynaud’s Hand Vascular Perfusion by Laser Doppler Normal Moderate Severe
  • 19. 19Fat Transfer in Raynaud’s Hand Vascular Perfusion by Laser Doppler
  • 20. 20Fat Transfer in Raynaud’s Hand Vascular Perfusion by Laser Doppler
  • 21. 21Fat Transfer in Raynaud’s Preop Postop 200 150 100 50 Perfusionunits Hand Vascular Perfusion by Laser Doppler ?QMRADASH
  • 22. Durable clinical improvement in the majority of treated patients Safe, relatively straightforward Mechanism – to be elucidated (stem cell angiogenesis? padding?) Role in treatment of advanced, refractory Raynaud’s Phenomenon 22 Conclusions Fat Transfer in Raynaud’s

Editor's Notes

  1. Thank you for allowing me to present here today
  2. Raynaud’s phenomenon is a common affliction effecting 2% of the adult population, More commonly in woman It results from an imbalance between vasodilation and vasoconstriction
  3. It can be divided in to primary raynaud, which usually exists in isolation from systemic disease and in which the vasoconstriction results in cold attacks an pain, which can be severe and debilitating Secondary raynauds typically occurs in the setting of autoimmune diseases such as systemic sclerosis (or scleroderma) And manifests in fibrosis, scarring, contractures, ulcerations and even autoamputations Clearly there is a continuum of disease manifestation
  4. Initial treatment is preventative – with gloves and cold avoidance But many patients progress to require medical treatment with calcium channel blockers and topical nitrates And there is a whole host of other medications aimed at vasodilation and prevention of arterial thrombosis
  5. Despite all of these options, A portion of these patients develop severe, refractory symptoms And this is where the hand surgeon comes in to play, invoking invasive modalities With injection of neuromodulators such as botulinum toxin – which has shown to be effective, but short lived, and can be an arduous undertaking for the patient and surgeon when done in the clinic setting Another option would be surgical sympathectomy of the hands of affected feet – this is not a trivial undertaking, with inherent procedural risks, and requires somewhat specialized training and my not be long-lived with the regrowth of the stripped adventitia The intervention we propose he today is autologous fat grafting into the affected extremities
  6. The rationale here stems from the clinical improvement witnessed in radiation dermatitis treated with fat injection, and to a certain extent in burn reconstruction A published study from a murine model shower regression of hyperpigmentation, ulcers and fibrosis With histological correlates However, the mechanism is unknown, and thought to be related to repletion of adipose derived stems cells into the injured tissue Recognizing that the pathophysiology in raynauds is differet, we contend that the end result at the tissue level is similar
  7. We therefore set out to utilize fat grafting As a means to treat patients with refractory cases of raynauds
  8. We adapted a technique popularized by coleman for cosmetic rejuvenation of the hand by fat grafting And inject approximately 30 ccs of decanted fat from abdominal sources, Via blunt cannulae into the affcted extremity
  9. The fat is dispersed subcutaneously and deeper, along the vessels as follows 10 cc dorsum of the hand 3 ml in the snuff box 2-3 in each dorsal webspace 6 cc along the palmar arch, the palmar webspaces and along the digital vessels
  10. Here you can see the fat being injected while withdrawing the cannula
  11. Over the past couple of years we performed this procedure on 14 patients Or 25 extremities Mainly in the hands With a mean follow up of one year Most of the patients severe females with primary raynauds The average amount of fat was about 23 cc And four had concomitant single digit sympathectomy for critical ischemia
  12. All in all – We some some levelof improvement in the vast majority of our patients Primary in pain relief Althou one patient reported no change And would stated her pain was actually worse In the patients that had ulcerations – two thirds were much improved or healed Two patients required further interventions at a 3-6 month interval
  13. It may be difficult to appreciate the subtle coloration improvement in this case
  14. But here you can clearly see the healing of several ulcers In the patient with severe scleroderma
  15. With overall improvement suggested by here wearing her ring again
  16. An example of fat transfer to the feet
  17. We attempted to further quantify and monitor this intervention With speckle laser doppler that gives an idea as to the perfusion to the studied area
  18. And this is an example of a clinically improved patient with a correlating improvement in measured perfusion
  19. However, not all of our outcomes were as encouraging
  20. We really had a range of measured responses that did not directly correlate with our clinical obserations And we are are still working out how to utilize this technology And are in the process of using other objective measure sucha s the DASH score whch grades function As well as quantitative MRA for a better assessment of tissue perfusion and longevity of the far grafts 5 showed LD improvement – 4/5 improved clinically, but the impovement was not sig in the LD 5 LD decrease – 4/5 improved symptoms
  21. In conclusion we found fat transfer in patients with raynauds phenomenon of varying degrees Provides a durable clinical improvement in the majority of treated patients It appears to be safe and relatively straightforward The precise mechanism has yet to be elucidated – and perhaps has to do with neoangiogenesis and decreased scar promoted by stem cells Although I think in the scleroderma patients – even the small amount of fat that survives, Provides a little bit of padding and cushioning to their severely sclerotic digits So we think that there is definitely a role for fat transfer in advanced, refractory raynauds phenomenon And look forward to collaborating with other surgeons on this project